Using Biomarkers to Plan Adjuvant Therapy in Breast Cancer

Lisa Carey, MD, will discuss the anatomic and genomic variables that impact on (neo)adjuvant decision-making in breast cancer and the current treatment algorithms that allow rational escalation and de-escalation of systemic therapy.

Course summary
Available credit: 
  • 1.00 Participation

    UNC Lineberger Cancer Network certificate of participation.

    Tim Poe, Director of Telehealth

Course opens: 
08/10/2021
Course expires: 
12/31/2026
Cost:
$0.00
Rating: 
0

Available Credit

  • 1.00 Participation

    UNC Lineberger Cancer Network certificate of participation.

    Tim Poe, Director of Telehealth

Price

Cost:
$0.00
Please login or register to take this course.